The Role of Metabotropic Glutamate Receptor Genes in Schizophrenia

  • Maj C
  • Minelli A
  • Giacopuzzi E
  • et al.
15Citations
Citations of this article
43Readers
Mendeley users who have this article in their library.
Get full text

Abstract

© 2016 Bentham Science Publishers.Genomic studies revealed two main components in the genetic architecture of schizophrenia, one constituted by common variants determining a distributed polygenic effect and one represented by a large number of heterogeneous rare and highly disruptive mutations. These gene modifications often affect neural transmission and different studies proved an involvement of metabotropic glutamate receptors in schizophrenia phenotype. Through the combination of literature information with genomic data from public repositories, we analyzed the current knowledge on the involvement of genetic variations of the human metabotropic glutamate receptors in schizophrenia and related endophenotypes. Despite the analysis did not reveal a definitive connection, different suggestive associations have been identified and in particular a relevant role has emerged for GRM3 in affecting specific schizophrenia endophenotypes. This supports the hypothesis that these receptors are directly involved in schizophrenia disorder.

Cite

CITATION STYLE

APA

Maj, C., Minelli, A., Giacopuzzi, E., Sacchetti, E., & Gennarelli, M. (2015). The Role of Metabotropic Glutamate Receptor Genes in Schizophrenia. Current Neuropharmacology, 14(5), 540–550. https://doi.org/10.2174/1570159x13666150514232745

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free